Fucosylated exosomal miRNAs as promising biomarkers for the diagnosis of early lung adenocarcinoma
BackgroundConsidering the absence of apparent symptoms at the early stage, most patients with lung adenocarcinoma (LUAD) present at an advanced stage, leading to a dismal 5-year survival rate of <20%. Thus, finding perspective non-invasive biomarkers for early LUAD is very essential.MethodsWe...
Main Authors: | Xiongfeng Chen, Lili Yu, Kun Hao, Xiaoqing Yin, Mingshu Tu, Liqing Cai, Liangming Zhang, Xiaojie Pan, Qi Gao, Yi Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.935184/full |
Similar Items
-
MiR-942-5p inhibits tumor migration and invasion through targeting CST1 in esophageal squamous cell carcinoma.
by: Liangming Zhang, et al.
Published: (2023-01-01) -
Tumor-suppressive miR-4732-3p is sorted into fucosylated exosome by hnRNPK to avoid the inhibition of lung cancer progression
by: Wanzhen Zhuang, et al.
Published: (2024-04-01) -
(Semi)-Synthetic Fucosylated Chondroitin Sulfate Oligo- and Polysaccharides
by: Giulia Vessella, et al.
Published: (2020-06-01) -
Exploring the diverse biological significance and roles of fucosylated oligosaccharides
by: Burcu Pekdemir, et al.
Published: (2024-05-01) -
Characterization of the Hydrolysis Kinetics of Fucosylated Glycosaminoglycan in Mild Acid and Structures of the Resulting Oligosaccharides
by: Xixi Liu, et al.
Published: (2020-05-01)